| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |